SCHEMBL3790971

SCHEMBL3790971

COC(=O)Nc1cccc(B(O)O)c1NC(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.43
PLAU P00749 1/20 0.41
ALDH1A1 P00352 6/20 0.41
LMNA P02545 2/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
HTT P42858 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
FAAH O00519 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPK1 P28482 1/20 0.38
PKM P14618 2/20 0.36
MAPT P10636 1/20 0.36
LPAR1 Q92633 1/20 0.36
ENPP2 Q13822 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790194 0.84 ALDH1A1 (0.56) HPGDALDH1A1LMNAHSD17B10KDM4E
SCHEMBL3780741 0.84 RXFP1 (0.43) LMNAKMT2AMEN1POLB
SCHEMBL3638868 0.84 HPGD (0.49) HPGDPLAUALDH1A1LMNAALOX15
SCHEMBL3780998 0.84 ALDH1A1 (0.52) HPGDALDH1A1KDM4EKMT2AMEN1
SCHEMBL3792868 0.80 HPGD (0.47) HPGDPLAUALDH1A1LMNAALOX15
SCHEMBL3786419 0.79 NPC1 (0.62) PLAUALDH1A1HSD17B10SMN1; SMN2CYP3A4
SCHEMBL3792891 0.79 ALDH1A1 (0.48) HPGDALDH1A1HSD17B10KDM4EKMT2A
SCHEMBL1023162 0.79 HPGD (0.50) HPGDPLAUALDH1A1LMNAALOX15
SCHEMBL3793403 0.77 NLRP3 (0.53) HPGDALDH1A1KDM4EKMT2AMEN1
SCHEMBL11659356 0.75 HPGD (0.64) HPGDPLAUALDH1A1LMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 HPGD 2790/4885PLAU 4396/4885ALDH1A1 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.